Standard Biotools (LAB) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)
Powered by 
Analysis
Standard Biotools (LAB) Net Income towards Common Stockholders Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 8.89% |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | -7.69% |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 48.30% |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | 42.35% |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | 13.37% |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 6.14% |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 32.37% |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | -36.74% |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | 34.02% |
| 10 | Standard Biotools | 285.26 Mn | -191.45 Mn | 10.54 Mn | -16.25% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16.25% |
| Mar 31, 2026 | 112.00% |
| Dec 31, 2025 | 43.01% |
| Sep 30, 2025 | -5.64% |
| Jun 30, 2025 | 19.25% |
| Mar 31, 2025 | 30.11% |
| Sep 30, 2024 | 18.53% |
| Jun 30, 2024 | -8.34% |
| Mar 31, 2024 | -19.61% |
| Dec 31, 2023 | 40.83% |
| Sep 30, 2023 | -51.95% |
| Jun 30, 2023 | -9.40% |
| Mar 31, 2023 | -1.89% |
| Dec 31, 2022 | -17.91% |
| Sep 30, 2022 | -31.79% |
| Jun 30, 2022 | -66.55% |
| Mar 31, 2022 | -44.14% |
| Sep 30, 2021 | -50.09% |
| Jun 30, 2021 | -30.33% |
| Mar 31, 2021 | -12.41% |